Glomset J A
J Lipid Res. 1968 Mar;9(2):155-67.
Evidence for the existence of a plasma lecithin : cholesterol acyltransferase is reviewed with emphasis not only on the lipid reactants, but also on the lipoprotein "substrates" and "products." The cholesteryl esters of all major lipoprotein classes become labeled when plasma is incubated with cholesterol-(14)C. However, the smaller, lecithin-rich high density lipoproteins appear to be preferred substrates. Most studies of factors that influence the acyltransferase reaction have not adequately distinguished between effects on the enzyme and effects on the lipoprotein substrates. However, the fact that cholesterol esterification is diminished in plasma from eviscerated animals or from patients with reduced liver function suggests that the liver may regulate both the level of the enzyme and that of the substrates. Several indications exist that the acyltransferase reaction is the major source of plasma esterified cholesterol in man. Furthermore, the reaction may have a broader, extracellular function. One possibility is that it plays a role in the transport of cholesterol from peripheral tissues to the liver.
胆固醇酰基转移酶存在的证据得到了综述,重点不仅放在脂质反应物上,还放在脂蛋白“底物”和“产物”上。当血浆与胆固醇 - ¹⁴C一起孵育时,所有主要脂蛋白类别的胆固醇酯都会被标记。然而,较小的、富含卵磷脂的高密度脂蛋白似乎是更受青睐的底物。大多数关于影响酰基转移酶反应因素的研究,并未充分区分对酶的影响和对脂蛋白底物的影响。然而,去内脏动物或肝功能减退患者的血浆中胆固醇酯化减少这一事实表明,肝脏可能同时调节酶的水平和底物的水平。有若干迹象表明,酰基转移酶反应是人体血浆酯化胆固醇的主要来源。此外,该反应可能具有更广泛的细胞外功能。一种可能性是它在胆固醇从外周组织向肝脏的转运中起作用。